After nearly 15 years in the PACS archive outsourcing business, Emerald Archiving is calling it quits. The company officially closed its doors in December. Emerald provided backfile image conversion services to help PACS customers make the
After nearly 15 years in the PACS archive outsourcing business, Emerald Archiving is calling it quits. The company officially closed its doors in December. Emerald provided backfile image conversion services to help PACS customers make the transition from film to DICOM and to migrate from an existing archive to a new archive. Despite having worked with two dozen hospitals across the U.S., as well as some sites in Canada and Italy, the company was never able to turn a profit and ultimately ran out of money, according to former president and CEO Joe Friedman.
"The PACS market is going forward a lot more slowly than people expected, and we didn't have the financial backing to 'stay the course,'" he said. "But I still believe this is a valid concept and there is an opportunity for someone to have a viable company."
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.